The authors here, by comparing proteomics and transcriptomics data, indicated that all the mediators within mitochondrial respiration network were underrepresented in MFS versus controls, thus the alterations between syndromic and non-syndromic TAA originated from mitochondrial dysfunction, especially in MFS patients with FBN1 haploinsufficiency. The gene discussed is FBN1; the disease is Marfan syndrome.